The Hanson Institute of South Australia, is the home of our core technology - unrivaled in the world of MSC/MPC technology. The ability to locate and extract highly pure populations of our cells. Keep in mind many of the firms claiming to advance in this area, are not developing "off-the-shelf" product, but individual based treatment, meaning considerable expense and technical limitation. Our approach, likely requires a bit longer in the clinical trial stage, BUT, the pay off is without equal!
Our CEO knows exactly where we are and he's already recently made a statement, which should have made everyone, including Mr Market, very excited, needless to say, it went unnoticed by many, including Mr Market!
MSB Price at posting:
$4.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)